Low rate of new white lesions detected after TCAR using diffusion-weighted MRI 

Raghu Motaganahalli

New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularization (TCAR), a study in which patients were assessed post-procedurally using diffusion-weighted magnetic resonance imaging (DW-MRI), has found. 

This was the finding delivered by Raghu Motaganahalli, MD, who presented data from a multicenter, single-arm, open-label study evaluating the incidence and volume of new white lesions occurring within 30 days after TCAR. Motaganahalli told attendees of Plenary 2 at the 2022 Vascular Annual Meeting (VAM) Wednesday morning that the outcomes of the analysis should serve as the benchmark for future comparisons evaluating carotid revascularization strategies on cerebral new white lesions. 

Diffusion-weighted imaging has high sensitivity and specificity for the early detection of ischemic lesions, Motaganahalli detailed in his presentation, noting that on DW-MRI, early ischemic lesions appear as new white lesions. Data from previous studies suggest that there is around a 17% chance of patients developing new white lesions following a TCAR procedure, Motaganahalli said, adding that the study presented at VAM 2022 is the first in the U.S. to evaluate the occurrence of new white lesions using DW-MRI. 

For the study, a total of 55 patients were enrolled across five centers from the U.S., as well as centers in Madrid, Spain, and Munich, Germany. Each patient underwent three MRI scans, one within the 72 hours preceding the TCAR procedure, another before their discharge from hospital, and a third at 30-day follow-up. 

Relating to the study’s primary endpoint, detection of new white lesions from the DW-MRI scan, Motaganahalli detailed that new white lesions were seen in 14.5% of patients prior to the TCAR procedure, with a mean volume of 0.11cc. New white lesions were then seen in 21.8% of the study population in scans taking place between 12–60 hours post-procedure, with a mean volume of 0.03cc. Predominantly these were distributed in the territory of the middle cerebral artery, Motaganahalli said. 

“When you look at the 30-day follow-up, the majority of these lesions disappear,” Motaganahalli then detailed, adding that lesions persisted in only 5.8% of the patients assessed at this timepoint. The mean volume of the lesions at this point was 0.21cc, which were again predominantly located in the territory of the middle cerebral artery. No incidences of stroke or neurological death, the study’s secondary endpoints, were seen. 

“Patients who underwent transcarotid artery revascularization and DW-MRI post-procedurally had a low incidence of new white lesions,” the presenter told attendees of the Plenary 2 session. Of these, he added, the majority were in the ipsilateral hemisphere, and located in the middle cerebral artery territory and distribution. 

“These lesions are very small, and those procedures [when] followed-up the majority of them are resolved,” Motaganahalli added. The results of the study should serve as a benchmark, and point to the detection of new white lesions as a surrogate marker for future carotid revascularization clinical trials, he concluded. 


Please enter your comment!
Please enter your name here